

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $5.45
Latest analyst grade actions
795 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2024-12-24
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 55.60 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 48.93 | Oscillator | Neutral |
| Williams %R (14) | -27.78 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.09 (Hist -0.04) | Oscillator | Sell |
| Average Directional Index (14) | 14.48 (+DI 20.1 / -DI 16.6) | Trend | Neutral |
| EMA 20 | 5.56 | MA | Buy |
| SMA 20 | 5.61 | MA | Buy |
| EMA 50 | 5.27 | MA | Strong Buy |
| SMA 50 | 5.19 | MA | Strong Buy |
| SMA 200 | 4.10 | MA | Strong Buy |
Stock news · updated daily
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jan 27, 2025 | — | -0.10 | — | $27.27K |
| Oct 30, 2024 | — | -0.07 | — | $40.77K |
| Apr 30, 2024 | — | -0.04 | — | $75.00K |
| Mar 20, 2024 | — | -0.07 | — | $76.33K |
| Jan 29, 2024 | — | -0.07 | — | $53.91K |
| Oct 30, 2023 | — | -0.06 | — | $43.19K |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
TTM vs. 5-year historical average (annual ratios)
| Metric | ACTHF | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -21.2x | -11.2x · sector 18.4x | Discount |
| Forward P/E | — | — | n/a |
| Price / Book | 24.5x | 6.3x | Elevated |
| Price / Sales | 615.5x | 224.8x | Elevated |
| EV / EBITDA | -29.3x | -14.9x | Elevated |
| Return on equity | -111.6% | — | Weak |
| Gross margin | 100.0% | 48.0% | Above hist. |
| Debt / Equity | 0.02 | -0.00 | Conservative |
| Piotroski / Altman Z | 3/9 | Z 139.76 | Safe zone |
Discounted cash flow model
SEC EDGAR filings · last 12 months
Proxy statement (DEF 14A) disclosures